Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -1,327 | -982 | -557 | N/A |
| Other Working Capital | N/A | 116 | 89 | 115 | N/A |
| Other Operating Activity | 0 | -521 | -250 | 41 | 0 |
| Operating Cash Flow | $N/A | $-1,732 | $-1,142 | $-401 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-1 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,676 | 1,258 | 171 | N/A |
| Other Financing Activity | 0 | 4 | 3 | 3 | 0 |
| Financing Cash Flow | $N/A | $1,680 | $1,261 | $174 | $N/A |
| Exchange Rate Effect | N/A | 2 | 1 | 5 | N/A |
| Beginning Cash Position | N/A | 337 | 337 | 337 | N/A |
| End Cash Position | N/A | 286 | 457 | 115 | N/A |
| Net Cash Flow | $N/A | $-51 | $120 | $-222 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -1,732 | -1,142 | -401 | N/A |
| Capital Expenditure | N/A | -1 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -1,732 | -1,142 | -401 | 0 |